Diagnostic Testing Market Report and Forecast 2025-2034
Description
The global diagnostic testing market size was valued at USD 191.55 Billion in 2024, driven by the increasing innovation in diagnostic testing techniques across the globe. The market size is anticipated to grow at a CAGR of 8.10% during the forecast period of 2025-2034 to achieve a value of USD 417.39 Billion by 2034.
Diagnostic Testing: Introduction
Diagnosis testing, a fundamental pillar of modern healthcare, involves a diverse range of tests and examinations aimed at identifying the presence of specific diseases, conditions, or health issues in individuals. Through laboratory tests, imaging techniques, genetic analysis, biopsies, and other diagnostic procedures, healthcare professionals can make accurate and timely diagnoses. Early detection facilitated by these tests enables prompt intervention and treatment, leading to improved patient outcomes.
Diagnostic testing not only confirms or rules out suspected diagnoses but also plays a crucial role in disease monitoring and the implementation of personalized medicine approaches. Additionally, it is instrumental in public health surveillance, allowing for the monitoring of infectious diseases and timely containment of outbreaks.
Global Diagnostic Testing Market Analysis
Diagnostic testing provides convenience, faster results, and ease of use for patients and healthcare providers, leading to increased demand for point-of-care testing (POCT). With the help of POCT devices, rapid diagnosis and treatment decisions could be made quickly in clinics, or even in remote settings, which leads to the reduction in time of fetching test results. These benefits increase the demand for better diagnostic testing procedures that are convenient for both healthcare professionals and the patients, driving the market growth.
Additionally, due to its great sensitivity and specificity in detecting and analyzing genetic material, infections, and biomarkers, molecular diagnostics is also experiencing substantial growth, which is directly adding up to the global diagnostic testing market share. The integration of diagnostic testing with digital health technologies, such as telemedicine, mobile health apps, and wearable devices, has also gained enough popularity among patients and healthcare professionals. With the help of these technologies, remote monitoring, data collection, and real-time communication between patients and healthcare providers is made easy which further enhances the overall patient experience and improves the disease management approaches.
To keep up with the needs of modern healthcare, the market is constantly evolving. The market is changing, and diagnostic skills are being upgraded for better patient care as a result of technological innovations, personalized healthcare, digital health integration, and ongoing responses to global health concerns.
Global Diagnostic Testing Market Segmentations
Diagnostic Testing Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Test
The market is a rapidly evolving and is an important part of the healthcare industry across the globe. It includes a wide range of procedures and equipment for examining illnesses, disorders, infections, and genetic disorders in people. The rising geriatric population, improvements in diagnostic technology, the rising demand for early disease diagnosis, and increasing focus on personalized medicines and healthcare, integration of smart technologies such as artificial intelligence and machine learning with diagnostic devices are some of the major factors that have been propelling the global diagnostic testing market growth. There are some major kinds of diagnostic testing included in the market which are molecular diagnostics, immunoassays, point-of-care testing, clinical chemistry, and medical imaging.
Diagnostic testing continues to play an important role in enhancing patient outcomes, enhancing treatment plans, and promoting effective disease management as the focus on preventative healthcare and quick treatments is increasing.
Moreover, the ongoing efforts to fight global health crises have further showed the significance of diagnostic testing in identifying and containing infectious diseases. With ongoing research and technological innovations, the market is expected to witness substantial growth in the coming years, contributing significantly to advancing healthcare and promoting better public health outcomes.
Diagnostic Testing Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Diagnostic Testing: Introduction
Diagnosis testing, a fundamental pillar of modern healthcare, involves a diverse range of tests and examinations aimed at identifying the presence of specific diseases, conditions, or health issues in individuals. Through laboratory tests, imaging techniques, genetic analysis, biopsies, and other diagnostic procedures, healthcare professionals can make accurate and timely diagnoses. Early detection facilitated by these tests enables prompt intervention and treatment, leading to improved patient outcomes.
Diagnostic testing not only confirms or rules out suspected diagnoses but also plays a crucial role in disease monitoring and the implementation of personalized medicine approaches. Additionally, it is instrumental in public health surveillance, allowing for the monitoring of infectious diseases and timely containment of outbreaks.
Global Diagnostic Testing Market Analysis
Diagnostic testing provides convenience, faster results, and ease of use for patients and healthcare providers, leading to increased demand for point-of-care testing (POCT). With the help of POCT devices, rapid diagnosis and treatment decisions could be made quickly in clinics, or even in remote settings, which leads to the reduction in time of fetching test results. These benefits increase the demand for better diagnostic testing procedures that are convenient for both healthcare professionals and the patients, driving the market growth.
Additionally, due to its great sensitivity and specificity in detecting and analyzing genetic material, infections, and biomarkers, molecular diagnostics is also experiencing substantial growth, which is directly adding up to the global diagnostic testing market share. The integration of diagnostic testing with digital health technologies, such as telemedicine, mobile health apps, and wearable devices, has also gained enough popularity among patients and healthcare professionals. With the help of these technologies, remote monitoring, data collection, and real-time communication between patients and healthcare providers is made easy which further enhances the overall patient experience and improves the disease management approaches.
To keep up with the needs of modern healthcare, the market is constantly evolving. The market is changing, and diagnostic skills are being upgraded for better patient care as a result of technological innovations, personalized healthcare, digital health integration, and ongoing responses to global health concerns.
Global Diagnostic Testing Market Segmentations
Diagnostic Testing Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Test
- Lipid Panel
- Liver Panel
- Renal Panel
- Complete Blood Count
- Electrolyte Testing
- Infectious Disease Testing
- Other Tests
- Product
- Instruments
- Reagents
- Other Products
- Hospital Laboratory
- Diagnostic Laboratory
- Point-of-care Testing
- Other End Users
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market is a rapidly evolving and is an important part of the healthcare industry across the globe. It includes a wide range of procedures and equipment for examining illnesses, disorders, infections, and genetic disorders in people. The rising geriatric population, improvements in diagnostic technology, the rising demand for early disease diagnosis, and increasing focus on personalized medicines and healthcare, integration of smart technologies such as artificial intelligence and machine learning with diagnostic devices are some of the major factors that have been propelling the global diagnostic testing market growth. There are some major kinds of diagnostic testing included in the market which are molecular diagnostics, immunoassays, point-of-care testing, clinical chemistry, and medical imaging.
Diagnostic testing continues to play an important role in enhancing patient outcomes, enhancing treatment plans, and promoting effective disease management as the focus on preventative healthcare and quick treatments is increasing.
Moreover, the ongoing efforts to fight global health crises have further showed the significance of diagnostic testing in identifying and containing infectious diseases. With ongoing research and technological innovations, the market is expected to witness substantial growth in the coming years, contributing significantly to advancing healthcare and promoting better public health outcomes.
Diagnostic Testing Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Becton, Dickinson and Company
- BioMerieux
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Siemens AG
- Hologic Inc.
- Qiagen NV
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific
- Quest Diagnostics Inc.
- Sysmex Corporation
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Diagnostic Testing Market Overview
- 3.1 Global Diagnostic Testing Market Historical Value (2018-2024)
- 3.2 Global Diagnostic Testing Market Forecast Value (2025-2034)
- 4 Global Diagnostic Testing Market Landscape
- 4.1 Global Diagnostic Testing: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Diagnostic Testing: Product Landscape
- 4.2.1 Analysis by Test Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Diagnostic Testing Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Diagnostic Testing Market Segmentation
- 6.1 Global Diagnostic Testing Market by Test
- 6.1.1 Market Overview
- 6.1.2 Lipid Panel
- 6.1.3 Liver Panel
- 6.1.4 Renal Panel
- 6.1.5 Complete Blood Count
- 6.1.6 Electrolyte Testing
- 6.1.7 Infectious Disease Testing
- 6.1.8 Other Tests
- 6.2 Global Diagnostic Testing Market by Type
- 6.2.1 Market Overview
- 6.2.2 Product
- 6.2.3 Instruments
- 6.2.4 Reagents
- 6.2.5 Other Products
- 6.3 Global Diagnostic Testing Market by End User
- 6.3.1 Market Overview
- 6.3.2 Hospital Laboratory
- 6.3.3 Diagnostic Laboratory
- 6.3.4 Point-of-care Testing
- 6.3.5 Other End Users
- 6.4 Global Diagnostic Testing Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Diagnostic Testing Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Diagnostic Testing Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Diagnostic Testing Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Diagnostic Testing Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Diagnostic Testing Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Clinical Trials Analysis
- 15.1 Analysis by Trial Registration Year
- 15.2 Analysis by Trial Status
- 15.3 Analysis by Trial Phase
- 15.4 Analysis by Therapeutic Area
- 15.5 Analysis by Geography
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Type of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Partnership and Collaborations Analysis
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership
- 17.3 Analysis by Leading Players
- 17.4 Analysis by Geography
- 18 Supplier Landscape
- 18.1 Abbott Laboratories
- 18.1.1 Financial Analysis
- 18.1.2 Product Portfolio
- 18.1.3 Demographic Reach and Achievements
- 18.1.4 Mergers and Acquisitions
- 18.1.5 Certifications
- 18.2 Becton, Dickinson and Company
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Mergers and Acquisitions
- 18.2.5 Certifications
- 18.3 BioMerieux
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Mergers and Acquisitions
- 18.3.5 Certifications
- 18.4 Bio-Rad Laboratories Inc.
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Mergers and Acquisitions
- 18.4.5 Certifications
- 18.5 Danaher Corporation
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Mergers and Acquisitions
- 18.5.5 Certifications
- 18.6 Siemens AG
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Mergers and Acquisitions
- 18.6.5 Certifications
- 18.7 Hologic Inc.
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Mergers and Acquisitions
- 18.7.5 Certifications
- 18.8 Qiagen NV
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Mergers and Acquisitions
- 18.8.5 Certifications
- 18.9 F. Hoffmann-La Roche AG
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Mergers and Acquisitions
- 18.9.5 Certifications
- 18.10 Thermo Fisher Scientific
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Mergers and Acquisitions
- 18.10.5 Certifications
- 18.11 Quest Diagnostics Inc.
- 18.11.1 Financial Analysis
- 18.11.2 Product Portfolio
- 18.11.3 Demographic Reach and Achievements
- 18.11.4 Mergers and Acquisitions
- 18.11.5 Certifications
- 18.12 Sysmex Corporation
- 18.12.1 Financial Analysis
- 18.12.2 Product Portfolio
- 18.12.3 Demographic Reach and Achievements
- 18.12.4 Mergers and Acquisitions
- 18.12.5 Certifications
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
